Exact Mass: 577.3743

Exact Mass Matches: 577.3743

Found 372 metabolites which its exact mass value is equals to given mass value 577.3743, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

LysoPC(22:1/0:0)

(2-{[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-hydroxypropyl phosphono]oxy}ethyl)trimethylazanium

C30H60NO7P (577.4107)

LysoPC(22:1(13Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:1(13Z)), in particular, consists of one chain of erucic acid at the C-1 position. The erucic acid moiety is derived from seed oils and avocados. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(22:1(13Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:1(13Z)), in particular, consists of one chain of erucic acid at the C-1 position. The erucic acid moiety is derived from seed oils and avocados. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

Dihydroergocryptine

N-[2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide

C32H43N5O5 (577.3264)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

PC(2:0/18:1(12Z)-O(9S,10R))

(2-{[(2R)-3-(acetyloxy)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propyl phosphono]oxy}ethyl)trimethylazanium

C28H52NO9P (577.338)

PC(2:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(12Z)-O(9S,10R)/2:0)

(2-{[(2R)-2-(acetyloxy)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propyl phosphono]oxy}ethyl)trimethylazanium

C28H52NO9P (577.338)

PC(18:1(12Z)-O(9S,10R)/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(12Z)-O(9S,10R)/2:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(2:0/18:1(9Z)-O(12,13))

(2-{[(2R)-3-(acetyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propyl phosphono]oxy}ethyl)trimethylazanium

C28H52NO9P (577.338)

PC(2:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(9Z)-O(12,13)/2:0)

(2-{[(2R)-2-(acetyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propyl phosphono]oxy}ethyl)trimethylazanium

C28H52NO9P (577.338)

PC(18:1(9Z)-O(12,13)/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(9Z)-O(12,13)/2:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Destruxin A

C29H47N5O7 (577.3475)

D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

C-6 NBD-dihydro-Ceramide

N-[2R-hydroxy-1R-(hydroxymethyl)-3E-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino-hexanamide

C30H51N5O6 (577.3839)

Lys Phe Arg Lys

(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]pentanamido]hexanoic acid

C27H47N9O5 (577.37)

Gln Lys Phe Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H43N9O6 (577.3336)

Phe Gln Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]hexanoic acid

C26H43N9O6 (577.3336)

BE-43547B

C31H51N3O7 (577.3727)

16-butan-2-yl-10,11,14-trimethyl-13-propan-2-yl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone

NCGC00180336-03!16-butan-2-yl-10,11,14-trimethyl-13-propan-2-yl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone

C29H47N5O7 (577.3475)

Edpetinosine

C33H55NO7 (577.3978)

Origin: Plant; SubCategory_DNP: Steroidal alkaloids, Petilium alkaloids

16-butan-2-yl-10,11,14-trimethyl-13-propan-2-yl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone [IIN-based on: CCMSLIB00000847629]

NCGC00180336-03!16-butan-2-yl-10,11,14-trimethyl-13-propan-2-yl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone [IIN-based on: CCMSLIB00000847629]

C29H47N5O7 (577.3475)

16-butan-2-yl-10,11,14-trimethyl-13-propan-2-yl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone [IIN-based: Match]

NCGC00180336-03!16-butan-2-yl-10,11,14-trimethyl-13-propan-2-yl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone [IIN-based: Match]

C29H47N5O7 (577.3475)

Phe Ile Ile Trp

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Phe Ile Leu Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Phe Ile Trp Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Ile Trp Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Lys Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]hexanamido]-5-carbamimidamidopentanoic acid

C27H47N9O5 (577.37)

Phe Lys Gln Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C26H43N9O6 (577.3336)

Phe Lys Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanamido]hexanoic acid

C27H47N9O5 (577.37)

Phe Lys Arg Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C26H43N9O6 (577.3336)

Phe Leu Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Phe Leu Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Phe Leu Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Leu Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Gln Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]hexanamido]-5-carbamimidamidopentanoic acid

C26H43N9O6 (577.3336)

Phe Arg Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanamido]hexanoic acid

C27H47N9O5 (577.37)

Phe Arg Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanamido]-4-carbamoylbutanoic acid

C26H43N9O6 (577.3336)

Phe Arg Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]hexanoic acid

C26H43N9O6 (577.3336)

Phe Trp Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Trp Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Trp Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Phe Trp Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Ile Phe Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Ile Phe Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Ile Phe Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Ile Phe Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Ile Ile Phe Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Ile Ile Trp Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Ile Leu Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Ile Leu Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Ile Trp Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Ile Trp Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Ile Trp Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Ile Trp Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Lys Phe Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C27H47N9O5 (577.37)

Lys Phe Gln Arg

(2S)-5-carbamimidamido-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]butanamido]pentanoic acid

C26H43N9O6 (577.3336)

Lys Phe Arg Gln

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]pentanamido]-4-carbamoylbutanoic acid

C26H43N9O6 (577.3336)

Lys Lys Phe Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C27H47N9O5 (577.37)

Lys Lys Arg Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C27H47N9O5 (577.37)

Lys Gln Phe Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-phenylpropanamido]pentanoic acid

C26H43N9O6 (577.3336)

Lys Gln Arg Phe

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]pentanamido]-3-phenylpropanoic acid

C26H43N9O6 (577.3336)

Lys Arg Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-phenylpropanamido]hexanoic acid

C27H47N9O5 (577.37)

Lys Arg Phe Gln

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-3-phenylpropanamido]-4-carbamoylbutanoic acid

C26H43N9O6 (577.3336)

Lys Arg Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]hexanamido]-3-phenylpropanoic acid

C27H47N9O5 (577.37)

Lys Arg Gln Phe

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]-4-carbamoylbutanamido]-3-phenylpropanoic acid

C26H43N9O6 (577.3336)

Leu Phe Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Leu Phe Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Leu Phe Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Leu Phe Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Leu Ile Phe Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Leu Ile Trp Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Leu Leu Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H43N5O5 (577.3264)

Leu Leu Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Leu Trp Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Leu Trp Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Leu Trp Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Leu Trp Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Gln Phe Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C26H43N9O6 (577.3336)

Gln Phe Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C26H43N9O6 (577.3336)

Gln Lys Arg Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C26H43N9O6 (577.3336)

Gln Arg Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanoic acid

C26H43N9O6 (577.3336)

Gln Arg Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanoic acid

C26H43N9O6 (577.3336)

Arg Phe Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanamido]hexanoic acid

C27H47N9O5 (577.37)

Arg Phe Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanamido]-4-carbamoylbutanoic acid

C26H43N9O6 (577.3336)

Arg Phe Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-carbamoylbutanamido]hexanoic acid

C26H43N9O6 (577.3336)

Arg Lys Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanamido]hexanoic acid

C27H47N9O5 (577.37)

Arg Lys Phe Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanamido]-4-carbamoylbutanoic acid

C26H43N9O6 (577.3336)

Arg Lys Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]hexanamido]-3-phenylpropanoic acid

C27H47N9O5 (577.37)

Arg Lys Gln Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-4-carbamoylbutanamido]-3-phenylpropanoic acid

C26H43N9O6 (577.3336)

Arg Gln Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-phenylpropanamido]hexanoic acid

C26H43N9O6 (577.3336)

Arg Gln Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]hexanamido]-3-phenylpropanoic acid

C26H43N9O6 (577.3336)

Trp Phe Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Phe Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Phe Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Phe Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Ile Phe Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Ile Phe Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Ile Ile Phe

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Trp Ile Leu Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Trp Leu Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Leu Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C32H43N5O5 (577.3264)

Trp Leu Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

Trp Leu Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C32H43N5O5 (577.3264)

PC(16:0/5:1)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-4-pentenyl)oxy]-, inner salt, 4-oxide, (R)-

C29H56NO8P (577.3743)

PC(18:0/3:1)

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-2-propenyl)oxy]-, inner salt, 4-oxide, (R)-

C29H56NO8P (577.3743)

dihydro-α-ergocryptine

C32H43N5O5 (577.3264)

dihydro-β-ergocryptine

C32H43N5O5 (577.3264)

LPC(22:1)

Lysophosphatidylcholine(22:1W9/0:0)

C30H60NO7P (577.4107)

PC(22:1(11Z)/0:0)

1-(11Z-docosenoyl)-glycero-3-phosphocholine

C30H60NO7P (577.4107)

PS(22:2(13Z,16Z)/0:0)

1-(13Z,16Z-docosadienoyl)-glycero-3-phosphoserine

C28H52NO9P (577.338)

PC 21:1

1-octadecanoyl-2-(2E-propionyl)-sn-glycero-3-phosphocholine

C29H56NO8P (577.3743)

LPC 22:1

1-(13Z-docosenoyl)-sn-glycero-3-phosphocholine

C30H60NO7P (577.4107)

LPS 22:2

1-(13Z,16Z-docosadienoyl)-glycero-3-phosphoserine

C28H52NO9P (577.338)

OOV-PE

1-(9Z-octadecenoyl)-2-(5-oxo-valeroyl)-sn-glycero-3-phosphoethanolamine

C28H52NO9P (577.338)

Epicriptine

C32H43N5O5 (577.3264)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

BenzeneoctanaMide

C30H51N5O6 (577.3839)

Belizatinib

C33H44FN5O3 (577.3428)

Dihydroergocryptine

C32H43N5O5 (577.3264)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Methyl N-{(4s,5s)-5-[(L-Alanyl-L-Alanyl)amino]-4-Hydroxy-6-Phenylhexanoyl}-L-Valyl-L-Valinate

C29H47N5O7 (577.3475)

Tomatidine galactoside

C33H55NO7 (577.3978)

(2R,3S,4S,5R)-2-(hydroxymethyl)-6-[(1R,2S,4S,5S,6S,7S,8R,9S,12S,13S,16S,18S)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-piperidine]-16-yl]oxyoxane-3,4,5-triol

C33H55NO7 (577.3978)

PC(2:0/18:1(12Z)-O(9S,10R))

C28H52NO9P (577.338)

PC(18:1(12Z)-O(9S,10R)/2:0)

C28H52NO9P (577.338)

[(2R)-3-acetyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H52NO9P (577.338)

[(2R)-2-acetyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C28H52NO9P (577.338)

Cyclo(N-methyl-L-alanyl-beta-alanyl-(2R)-2-hydroxy-4-pentenoyl-L-prolyl-L-isoleucyl-N-methyl-L-valyl)

C29H47N5O7 (577.3475)

D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

Dihydro-beta-ergocryptine

C32H43N5O5 (577.3264)

beta-Ergocryptine in which a single bond replaces the double bond between positions 9 and 10.

N-(2-hydroxyhexanoyl)-beta-D-galactosylsphinganine

C30H59NO9 (577.419)

1-O-(1Z-hexadecenyl)-2-(5-oxopentanoyl)-sn-glycero-3-phosphocholine

C29H56NO8P (577.3743)

1-[[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

1-[[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

1-[[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

1-[[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

1-[[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

1-[[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

1-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide

C32H43N5O5 (577.3264)

1-[[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

1-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

1-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C30H51N5O6 (577.3839)

Tomatidine 3-glucoside

C33H55NO7 (577.3978)

[3-[(Z)-docos-13-enoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

HexCer 8:1;2O/18:5

C32H51NO8 (577.3614)

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C28H52NO9P (577.338)

Lnape 16:1/N-8:0

C29H56NO8P (577.3743)

Lnape 6:0/N-18:1

C29H56NO8P (577.3743)

Lnape 22:1/N-2:0

C29H56NO8P (577.3743)

Lnape 15:1/N-9:0

C29H56NO8P (577.3743)

Lnape 4:0/N-20:1

C29H56NO8P (577.3743)

Lnape 9:0/N-15:1

C29H56NO8P (577.3743)

Lnape 17:1/N-7:0

C29H56NO8P (577.3743)

Lnape 18:1/N-6:0

C29H56NO8P (577.3743)

Lnape 3:0/N-21:1

C29H56NO8P (577.3743)

Lnape 5:0/N-19:1

C29H56NO8P (577.3743)

Lnape 2:0/N-22:1

C29H56NO8P (577.3743)

Lnape 20:1/N-4:0

C29H56NO8P (577.3743)

Lnape 8:0/N-16:1

C29H56NO8P (577.3743)

Lnape 19:1/N-5:0

C29H56NO8P (577.3743)

Lnape 21:1/N-3:0

C29H56NO8P (577.3743)

Lnape 7:0/N-17:1

C29H56NO8P (577.3743)

[3-octoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

Lnape 11:0/N-13:1

C29H56NO8P (577.3743)

Lnape 13:1/N-11:0

C29H56NO8P (577.3743)

Lnape 10:0/N-14:1

C29H56NO8P (577.3743)

Lnape 14:1/N-10:0

C29H56NO8P (577.3743)

HexCer 9:0;3O/14:1;(2OH)

C29H55NO10 (577.3826)

HexCer 8:0;3O/15:1;(2OH)

C29H55NO10 (577.3826)

HexCer 11:0;3O/12:1;(2OH)

C29H55NO10 (577.3826)

HexCer 10:0;3O/13:1;(2OH)

C29H55NO10 (577.3826)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] (Z)-hexadec-9-enoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] pentanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] propanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] butanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (Z)-heptadec-9-enoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] hexanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] octanoate

C30H60NO7P (577.4107)

[3-[(Z)-heptadec-9-enoxy]-2-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[2-nonanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[3-[(Z)-nonadec-9-enoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[2-acetyloxy-3-[(Z)-icos-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[2-heptanoyloxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[3-nonoxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tridec-4-ene-1-sulfonic acid

C33H55NO5S (577.3801)

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid

C33H55NO5S (577.3801)

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid

C33H55NO5S (577.3801)

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]trideca-4,8-diene-1-sulfonic acid

C33H55NO5S (577.3801)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] dodecanoate

C30H60NO7P (577.4107)

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyundecane-1-sulfonic acid

C33H55NO5S (577.3801)

(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]pentadec-4-ene-1-sulfonic acid

C33H55NO5S (577.3801)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (Z)-tetradec-9-enoate

C30H60NO7P (577.4107)

(4E,8E,12E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid

C33H55NO5S (577.3801)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (Z)-tridec-9-enoate

C30H60NO7P (577.4107)

(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

C33H55NO5S (577.3801)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] decanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (Z)-pentadec-9-enoate

C30H60NO7P (577.4107)

(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

C33H55NO5S (577.3801)

(6E)-14-hydroxy-4,14,16-trimethyl-8-methylidene-17-(12-methyltridecyl)-1-oxa-4,9,12-triazacycloheptadec-6-ene-2,5,10,13,15-pentone

C31H51N3O7 (577.3727)

4-[3-heptanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C33H55NO7 (577.3978)

4-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-pentanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C33H55NO7 (577.3978)

4-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C33H55NO7 (577.3978)

[2-octanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] heptanoate

C30H60NO7P (577.4107)

[3-[(Z)-hexadec-9-enoxy]-2-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[2-butanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] nonanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] undecanoate

C30H60NO7P (577.4107)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tridec-9-enoate

C29H56NO8P (577.3743)

[3-butanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

[3-hexanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-docos-13-enoate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-icos-11-enoate

C29H56NO8P (577.3743)

[2-[(Z)-hexadec-9-enoyl]oxy-3-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C29H56NO8P (577.3743)

[3-acetyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C29H56NO8P (577.3743)

[3-heptanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C29H56NO8P (577.3743)

[2-[(Z)-octadec-9-enoyl]oxy-3-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H56NO8P (577.3743)

lysoPC 22:1

C30H60NO7P (577.4107)

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C33H55NO7 (577.3978)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C29H56NO8P (577.3743)

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C33H55NO7 (577.3978)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] (E)-tetradec-9-enoate

C29H56NO8P (577.3743)

LysoPC(22:1(13Z))

C30H60NO7P (577.4107)

1-(11Z-docosenoyl)-glycero-3-phosphocholine

C30H60NO7P (577.4107)

1-(13Z,16Z-docosadienoyl)-glycero-3-phosphoserine

C28H52NO9P (577.338)

lysophosphatidylcholine 22:1

C30H60NO7P (577.4107)

A lysophosphatidylcholine in which the remaining acyl group contains 22 carbons and 1 double bond. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

dihydro-alpha-ergocryptine

C32H43N5O5 (577.3264)

alpha-Ergocryptine in which a single bond replaces the double bond between positions 9 and 10.

MePC(21:1)

MePC(8:1(1)_13:0)

C30H60NO7P (577.4107)

MePC(20:1)

MePC(4:0_16:1)

C29H56NO8P (577.3743)

dMePE(22:1)

dMePE(4:0_18:1)

C29H56NO8P (577.3743)

DGCC 21:6;O

C31H47NO9 (577.3251)

DGCC 22:5

C32H51NO8 (577.3614)

DGTS 21:6;O2

C31H47NO9 (577.3251)

DGTS 22:5;O

C32H51NO8 (577.3614)

DGTS 23:4

C33H55NO7 (577.3978)

MGCC 23:5

C33H55NO7 (577.3978)

LPC 0:0/22:1

C30H60NO7P (577.4107)

LPC 22:1/0:0

C30H60NO7P (577.4107)

PC O-18:0/4:1

C30H60NO7P (577.4107)

PC O-18:1/4:0

C30H60NO7P (577.4107)

PC O-20:1/2:0

C30H60NO7P (577.4107)

PC O-20:3;O2

C28H52NO9P (577.338)

PC O-21:2;O

C29H56NO8P (577.3743)

PC O-22:1

C30H60NO7P (577.4107)

PC P-16:0/5:1;O

C29H56NO8P (577.3743)

PC P-16:1/4:1;O2

C28H52NO9P (577.338)

PC P-18:0/4:0

C30H60NO7P (577.4107)

PC P-18:0/4:0 or PC O-18:1/4:0

C30H60NO7P (577.4107)

PC P-20:0/2:0

C30H60NO7P (577.4107)

PC P-20:0/2:0 or PC O-20:1/2:0

C30H60NO7P (577.4107)

PC P-22:0

C30H60NO7P (577.4107)

PC P-22:0 or PC O-22:1

C30H60NO7P (577.4107)

LPC 20:3;O2

C28H52NO9P (577.338)

PC 14:0/6:2;O

C28H52NO9P (577.338)

PC 16:1/4:1;O

C28H52NO9P (577.338)

PC 20:2;O

C28H52NO9P (577.338)

PC 17:0/4:1

C29H56NO8P (577.3743)

PC 17:1/4:0

C29H56NO8P (577.3743)

LNAPE 23:2;O

C28H52NO9P (577.338)

LNAPE 24:1

C29H56NO8P (577.3743)

PE O-14:1/11:0

C30H60NO7P (577.4107)

PE O-16:0/7:3;O2

C28H52NO9P (577.338)

PE O-18:0/6:2;O

C29H56NO8P (577.3743)

PE O-23:3;O2

C28H52NO9P (577.338)

PE O-24:2;O

C29H56NO8P (577.3743)

PE O-25:1

C30H60NO7P (577.4107)

PE P-14:0/11:0

C30H60NO7P (577.4107)

PE P-14:0/11:0 or PE O-14:1/11:0

C30H60NO7P (577.4107)

PE P-16:0/7:2;O2

C28H52NO9P (577.338)

PE P-16:0/8:1;O

C29H56NO8P (577.3743)

PE P-18:1/5:1;O2

C28H52NO9P (577.338)

PE P-20:0/4:1;O

C29H56NO8P (577.3743)

PE P-25:0

C30H60NO7P (577.4107)

PE P-25:0 or PE O-25:1

C30H60NO7P (577.4107)

PE 14:1/9:1;O

C28H52NO9P (577.338)

PE 18:1/5:1;O

C28H52NO9P (577.338)

PE 10:0_14:1

C29H56NO8P (577.3743)

PE 20:0/4:1

C29H56NO8P (577.3743)

PE 20:1/4:0

C29H56NO8P (577.3743)

PE 22:1/2:0

C29H56NO8P (577.3743)

PE 24:1

C29H56NO8P (577.3743)

PS O-18:1/4:1

C28H52NO9P (577.338)

PS O-18:2/4:0

C28H52NO9P (577.338)

PS O-20:2/2:0

C28H52NO9P (577.338)

PS O-22:2

C28H52NO9P (577.338)

PS P-18:0/4:1

C28H52NO9P (577.338)

PS P-18:0/4:1 or PS O-18:1/4:1

C28H52NO9P (577.338)

PS P-18:1/4:0

C28H52NO9P (577.338)

PS P-18:1/4:0 or PS O-18:2/4:0

C28H52NO9P (577.338)

PS P-20:1/2:0

C28H52NO9P (577.338)

PS P-20:1/2:0 or PS O-20:2/2:0

C28H52NO9P (577.338)

PS P-22:1

C28H52NO9P (577.338)

PS P-22:1 or PS O-22:2

C28H52NO9P (577.338)

CerP 14:1;O2/16:0;O

C30H60NO7P (577.4107)

CerP 15:1;O2/15:0;O

C30H60NO7P (577.4107)

CerP 16:1;O2/14:0;O

C30H60NO7P (577.4107)

CerP 17:1;O2/13:0;O

C30H60NO7P (577.4107)

CerP 18:1;O2/12:0;O

C30H60NO7P (577.4107)

CerP 19:1;O2/11:0;O

C30H60NO7P (577.4107)

CerP 20:1;O2/10:0;O

C30H60NO7P (577.4107)

CerP 30:1;O2;O

C30H60NO7P (577.4107)

GalCer 14:0;O2/10:0;O

C30H59NO9 (577.419)

GalCer 14:0;O3/10:0

C30H59NO9 (577.419)

GalCer 24:0;O2;O

C30H59NO9 (577.419)

GalCer 24:0;O3

C30H59NO9 (577.419)

GlcCer 14:0;O2/10:0;O

C30H59NO9 (577.419)

GlcCer 14:0;O3/10:0

C30H59NO9 (577.419)

GlcCer 24:0;O2;O

C30H59NO9 (577.419)

GlcCer 24:0;O3

C30H59NO9 (577.419)

HexCer 14:0;O2/10:0;2OH

C30H59NO9 (577.419)

HexCer 14:0;O2/10:0;3OH

C30H59NO9 (577.419)

HexCer 14:0;O2/10:0;O

C30H59NO9 (577.419)

HexCer 14:0;O3/10:0

C30H59NO9 (577.419)

HexCer 24:0;O2;O

C30H59NO9 (577.419)

HexCer 24:0;O3

C30H59NO9 (577.419)

ST 29:4;O7;Gly

C31H47NO9 (577.3251)

ST 23:3;O4;HexNAc

C31H47NO9 (577.3251)

ST 24:2;O3;HexNAc

C32H51NO8 (577.3614)

ST 25:1;O2;HexNAc

C33H55NO7 (577.3978)

ST 27:7;O;HexNAc

C35H47NO6 (577.3403)

ST 26:0;O6;Tau

C28H51NO9S (577.3284)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,5r,5as,7s,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(5s)-5-methyl-1,4,5,6-tetrahydropyridin-2-yl]ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,5r,5as,7s,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(5s)-5-methyl-1,4,5,6-tetrahydropyridin-2-yl]ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

2-({17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1r,2s,4s,5's,6s,7s,8r,9s,12s,13s,16s,18s)-5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1r,2s,4s,5's,6s,7s,8r,9s,12s,13s,16s,18s)-5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy]oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6s,9s,10r,11s,14s,15s,17s,18s,20r,23r,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6s,9s,10r,11s,14s,15s,17s,18s,20r,23r,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5r,6r)-2-{[(1r,2r,3as,3bs,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2r,5s)-5-methylpiperidin-2-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,2r,3as,3bs,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2r,5s)-5-methylpiperidin-2-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

2-(hydroxymethyl)-6-{5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy}oxane-3,4,5-triol

C33H55NO7 (577.3978)

(3s,6s,9s,21as)-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3-(sec-butyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

(3s,6s,9s,21as)-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3-(sec-butyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

C29H47N5O7 (577.3475)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2r,5s)-5-methylpiperidin-2-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2r,5s)-5-methylpiperidin-2-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(2r,3as,3bs,7s,9ar,9bs,11ar)-2-[(1r)-1-hydroxy-1-[(2r,5s)-5-methylpiperidin-2-yl]ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2r,3as,3bs,7s,9ar,9bs,11ar)-2-[(1r)-1-hydroxy-1-[(2r,5s)-5-methylpiperidin-2-yl]ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3s,4r,5s,6s)-2-{[(1r,2r,6r,9r,10s,11r,14r,15r,17r,18s,21s,23s,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-21-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5s,6s)-2-{[(1r,2r,6r,9r,10s,11r,14r,15r,17r,18s,21s,23s,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-21-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(3s,6s,9s,16s,21as)-3-[(2r)-butan-2-yl]-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

(3s,6s,9s,16s,21as)-3-[(2r)-butan-2-yl]-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

C29H47N5O7 (577.3475)

(1r,2s,3s,4s,5r,6s,8r,12s,13s,16r,19s,20r,21s)-21-(acetyloxy)-14-ethyl-2-hydroxy-6,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-yl (2s)-2-methylbutanoate

(1r,2s,3s,4s,5r,6s,8r,12s,13s,16r,19s,20r,21s)-21-(acetyloxy)-14-ethyl-2-hydroxy-6,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-yl (2s)-2-methylbutanoate

C31H47NO9 (577.3251)

(3s,6s,9s,16s,21as)-3-[(2s)-butan-2-yl]-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

(3s,6s,9s,16s,21as)-3-[(2s)-butan-2-yl]-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

C29H47N5O7 (577.3475)

2-({2-[1-hydroxy-1-(5-methylpiperidin-2-yl)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5r,6r)-2-{[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2s,5s)-5-methylpiperidin-2-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2s,5s)-5-methylpiperidin-2-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(3r,4s,5s,6r)-2-{[(1r,3as,3bs,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-(5-methylpiperidin-2-yl)ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5s,6r)-2-{[(1r,3as,3bs,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(1s)-1-(5-methylpiperidin-2-yl)ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(6e,14r,16s,17s)-10,13,14-trihydroxy-4,14,16-trimethyl-8-methylidene-17-(11-methyltridecyl)-1-oxa-4,9,12-triazacycloheptadeca-6,9,12-triene-2,5,15-trione

C31H51N3O7 (577.3727)

(6e,14r,16s,17s)-10,13,14-trihydroxy-4,14,16-trimethyl-8-methylidene-17-tetradecyl-1-oxa-4,9,12-triazacycloheptadeca-6,9,12-triene-2,5,15-trione

C31H51N3O7 (577.3727)

2-({2-hydroxy-9a,11a-dimethyl-1-[1-(5-methylpiperidin-2-yl)ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6r,9s,11r,14s,15s,17r,18s,20s,23r,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6r,9s,11r,14s,15s,17r,18s,20s,23r,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6s,9s,11r,14s,15s,17r,18s,20s,23r,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6s,9s,11r,14s,15s,17r,18s,20s,23r,24s)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3-(sec-butyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

C29H47N5O7 (577.3475)

(2r,3r,4r,5r,6s)-2-{[(1s,2r,6s,9r,10s,11r,14r,15r,17r,18s,20s,23s,24r)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1s,2r,6s,9r,10s,11r,14r,15r,17r,18s,20s,23s,24r)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

2-({5-hydroxy-9a,11a-dimethyl-1-[1-(5-methyl-1,4,5,6-tetrahydropyridin-2-yl)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(2e,4r,5r,6e,8e,11e)-13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C31H47NO9 (577.3251)

(2r,3r,4s,5s,6r)-2-[(2e)-but-2-en-2-yl]-2-{[(3e,5e,8e)-10-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-8-methyldeca-3,5,8-trien-1-yl]oxy}-6-(hydroxymethyl)-3,5-dimethyloxane-3,4,5-triol

C31H47NO9 (577.3251)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,5r,5as,7s,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(5r)-5-methyl-1,4,5,6-tetrahydropyridin-2-yl]ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,5r,5as,7s,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-1-[(1s)-1-[(5r)-5-methyl-1,4,5,6-tetrahydropyridin-2-yl]ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6s,9s,10r,11r,14r,15s,17r,18s,20s,23r,24r)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6s,9s,10r,11r,14r,15s,17r,18s,20s,23r,24r)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6r,9s,10r,11r,14s,15s,17r,18s,20s,23r,24r)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,6r,9s,10r,11r,14s,15s,17r,18s,20s,23r,24r)-17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(3s,6s,9s,16r,21as)-3-[(2s)-butan-2-yl]-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

(3s,6s,9s,16r,21as)-3-[(2s)-butan-2-yl]-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

C29H47N5O7 (577.3475)

2-({2-[(2e,5e,7e,11e)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraen-1-yl]-5,6-dimethoxy-3-methylpyridin-4-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C31H47NO9 (577.3251)

2-({1-[1-hydroxy-1-(5-methylpiperidin-2-yl)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)

(2r,3r,4s,5s,6r)-2-({17-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosan-20-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H55NO7 (577.3978)